Global Atherectomy Devices Market Size and Forecast 2025–2033: Minimally Invasive Solutions Transforming Vascular Care

Global Atherectomy Devices Market Overview

The global atherectomy devices market is entering a high-growth phase as cardiovascular and peripheral vascular diseases continue to rise worldwide. According to Renub Research, the Atherectomy Devices Market is expected to reach US$ 2.21 billion by 2033, growing from US$ 1.05 billion in 2024, at a robust CAGR of 8.63% from 2025 to 2033.

Download Free Sample Report

Atherectomy devices are specialized medical tools designed to remove plaque buildup from arteries, restoring blood flow in patients suffering from coronary artery disease (CAD) or peripheral artery disease (PAD). Unlike balloon angioplasty or stenting, atherectomy physically removes or vaporizes plaque, making it particularly effective in complex or heavily calcified lesions where other procedures may fail.

With healthcare systems shifting toward minimally invasive treatments, atherectomy has emerged as a preferred option due to shorter recovery times, reduced complications, and better long-term vessel patency. These advantages, combined with technological innovation and growing awareness, are accelerating global adoption.

Why Atherectomy Is Gaining Global Momentum

The rising burden of lifestyle-related diseases such as diabetes, obesity, hypertension, and high cholesterol has led to a surge in arterial blockages, especially among aging populations. Peripheral artery disease alone affects millions globally and is a leading cause of disability in older adults.

Atherectomy devices offer a critical solution by enabling physicians to treat complex lesions with precision while minimizing vessel trauma. As a result, hospitals and ambulatory surgical centers are increasingly integrating atherectomy procedures into their vascular treatment protocols.

Key Trends Shaping the Atherectomy Devices Industry

1. Rapid Rise in Peripheral Artery Disease (PAD)

One of the most significant drivers of market growth is the alarming rise in PAD cases. In the United States alone, an estimated 8–12 million people are affected, with prevalence increasing sharply after the age of 50. Similar trends are emerging in Europe and Asia due to aging demographics and sedentary lifestyles.

Atherectomy devices play a vital role in PAD management by restoring arterial patency and reducing symptoms such as leg pain, fatigue, and mobility impairment. Their ability to treat calcified and complex lesions has positioned them as a key tool in advanced vascular interventions.

2. Technological Advancements in Device Design

Innovation is reshaping the atherectomy landscape. Modern devices now offer:

Higher precision and safety

Reduced vessel trauma

Improved procedural efficiency

Integration with real-time imaging technologies

Technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) allow physicians to visualize lesions more accurately, improving treatment outcomes.

In August 2022, AngioDynamics received FDA 510(k) clearance for expanded use of its Auryon Atherectomy System, including arterial thrombectomy—highlighting how regulatory approvals are accelerating market innovation.

3. Expansion into Emerging Markets

Emerging economies across Asia-Pacific, Latin America, the Middle East, and Africa are witnessing rapid improvements in healthcare infrastructure. Growing urbanization, rising disposable incomes, and increasing awareness of cardiovascular health are driving demand for advanced interventional procedures.

Government investments, public-private partnerships, and expanding insurance coverage are making atherectomy procedures more accessible, creating significant growth opportunities for global manufacturers.

Challenges Limiting Market Growth

Shortage of Skilled Operators

Atherectomy procedures require specialized training and technical expertise. The complexity of rotational, laser, and orbital systems can limit adoption in regions with limited access to skilled interventional specialists. Training programs are time-intensive and costly, which slows widespread penetration—especially in developing countries.

High Cost of Devices and Procedures

Atherectomy devices are technologically advanced and expensive, creating barriers for smaller healthcare facilities and price-sensitive markets. In regions with weak reimbursement frameworks, high procedural costs may limit patient access despite clinical benefits.

Regional Market Analysis

North America: Market Leader

North America dominates the global atherectomy devices market, supported by:

Advanced healthcare infrastructure

High PAD prevalence

Strong reimbursement systems

Rapid adoption of minimally invasive procedures

The region also benefits from the presence of major manufacturers and continuous clinical research.

United States Atherectomy Devices Market

The U.S. market is driven primarily by its aging population, with more than 55.8 million people aged 65+ as of 2023. PAD and atherosclerosis are highly prevalent due to obesity, diabetes, and high cholesterol levels.

According to CDC data (May 2024), around 25 million U.S. adults suffer from high cholesterol, significantly increasing the need for vascular interventions. Atherectomy devices are increasingly used to treat complex lesions, particularly in elderly and high-risk patients.

Europe: Strong Growth Driven by Aging Population

Europe holds the second-largest market share, led by Germany, France, and the UK. Rising PAD prevalence, favorable reimbursement policies, and widespread adoption of minimally invasive procedures are fueling demand.

Germany Atherectomy Devices Market

Germany’s well-developed healthcare system and strong focus on technological innovation are driving steady growth. The rising elderly population and high prevalence of diabetes and hyperlipidemia support long-term market expansion.

Asia-Pacific: Fastest Growing Region

Asia-Pacific is expected to register the fastest CAGR through 2033 due to:

Large patient population

Rapid healthcare modernization

Government healthcare reforms

Growing awareness of PAD and cardiovascular diseases

India Atherectomy Devices Market

India is emerging as a high-potential market due to a sharp rise in cardiovascular diseases driven by urban lifestyles. Increasing access to tertiary hospitals, improving insurance coverage, and growing acceptance of minimally invasive procedures are accelerating adoption.

Middle East & Africa: Emerging Opportunities

Countries like Saudi Arabia and the UAE are investing heavily in advanced medical technology. Healthcare modernization, aging populations, and rising cardiovascular disease incidence are creating strong demand for atherectomy devices.

Saudi Arabia Atherectomy Devices Market

Saudi Arabia’s healthcare transformation under Vision 2030 is boosting adoption of advanced interventional cardiology devices. Public and private investments in healthcare infrastructure are making atherectomy a standard treatment option in leading hospitals.

Market Segmentation Analysis

By Product Type

Directional Atherectomy

Rotational Atherectomy

Orbital Atherectomy

Laser Atherectomy

By Application

Cardiovascular

Neurovascular

Peripheral Vascular

By End User

Hospitals

Ambulatory Care Services

Medical Research Institutes

Hospitals currently dominate the market due to their advanced facilities and availability of skilled specialists, while ambulatory centers are growing rapidly due to cost efficiency and shorter patient stays.

Competitive Landscape: Key Players

The global atherectomy devices market is moderately consolidated, with leading companies focusing on product innovation, strategic partnerships, and geographic expansion.

Key Companies Covered in the Report:

Boston Scientific Corporation

Abbott Laboratories

Medtronic plc

Cardinal Health

Terumo Corporation

Integer Holdings Corporation

Becton, Dickinson and Company

AngioDynamics, Inc.

Each company is analyzed across five dimensions: overview, key leadership, product portfolio, recent developments, and revenue strategy.

Final Thoughts

The global atherectomy devices market is poised for sustained growth through 2033 as cardiovascular diseases continue to rise and healthcare systems increasingly embrace minimally invasive solutions. Technological innovation, expanding access in emerging markets, and favorable demographic trends are reshaping the future of vascular care.

Despite challenges related to cost and skill availability, the long-term outlook remains highly positive. As manufacturers continue to develop safer, smarter, and more efficient devices, atherectomy is set to become a cornerstone of modern interventional cardiology and peripheral vascular treatment worldwide.

With strong clinical benefits and rising global demand, atherectomy devices represent one of the most promising growth segments in the medical device industry.